These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4146392)

  • 21. Comparative pharmacokinetics of intravenous cephalexin in pregnant, lactating, and nonpregnant, nonlactating goats.
    Ambros L; Kreil V; Tarragona L; Monfrinotti A; Hallu R; Rebuelto M
    J Vet Pharmacol Ther; 2011 Aug; 34(4):397-402. PubMed ID: 20950353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic concentration in the serum of dogs and cats following a single oral dose of cephalexin.
    Crosse R; Burt DG
    Vet Rec; 1984 Aug; 115(5):106-7. PubMed ID: 6474784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioavailability of cephalexin after intramuscular injection of its lysine salt.
    Barrios S; Sorensen JH; Spickett RG
    J Pharm Pharmacol; 1975 Sep; 27(9):711-2. PubMed ID: 241820
    [No Abstract]   [Full Text] [Related]  

  • 24. Effectiveness and tolerance of cephalexin in children.
    Helwig H; Kunz H; Hueppchen C
    Z Kinderheilkd; 1972; 111(4):307-14. PubMed ID: 5015883
    [No Abstract]   [Full Text] [Related]  

  • 25. Penetration of antibiotic into interstitial tissue fluid following parenteral administration of lysine cephalexin.
    Cadórniga R; Barrios S; Segura J; Roberts DJ
    Arzneimittelforschung; 1979; 29(10):1547-9. PubMed ID: 583220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of two once-daily parenteral cephalexin formulations in dogs.
    Rebuelto M; Montoya L; Kreil V; Ambros L; Waxman S; Albarellos G; Hallu R
    J Vet Pharmacol Ther; 2005 Oct; 28(5):419-23. PubMed ID: 16207303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative pharmacokinetics of an injectable cephalexin suspension in beef cattle.
    Waxman Dova S; Albarellos G; Kreil V; Montoya L; Ambros L; Hallu R; Rebuelto M
    Res Vet Sci; 2008 Dec; 85(3):570-4. PubMed ID: 18433809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cephalosporins from the clinical viewpoint].
    Regamey C
    Int J Clin Pharmacol Biopharm; 1975 Mar; 11(2):93-102. PubMed ID: 1095504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Assay of blood and urinary levels of 2 different solutions of cephalexin for oral administration].
    Mesina P; Zanetti S; Contu MA
    G Batteriol Virol Immunol; 1984; 77(7-12):137-44. PubMed ID: 6545795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cephalexin in ponies: a preliminary investigation.
    Lees P; May SA; Hooke RE; Silley P
    Vet Rec; 1990 Jun; 126(26):635-7. PubMed ID: 2382364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and tissue fluid distribution of cephalexin in the horse after oral and i.v. administration.
    Davis JL; Salmon JH; Papich MG
    J Vet Pharmacol Ther; 2005 Oct; 28(5):425-31. PubMed ID: 16207304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-performance liquid chromatographic assay of cephalexin in serum and urine.
    Emm TA; Leslie J; Chai M; Lesko LJ; Perkal MB
    J Chromatogr; 1988 May; 427(1):162-5. PubMed ID: 3410897
    [No Abstract]   [Full Text] [Related]  

  • 33. Cephalexin: a review of its antibacterial, pharmacological and therapeutic properties.
    Speight TM; Brogden RN; Avery GS
    Drugs; 1972; 3(1):9-78. PubMed ID: 4559812
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cephalexin levels in the bronchial secretion of children (author's transl)].
    Daschner F
    MMW Munch Med Wochenschr; 1977 Mar; 119(10):339-40. PubMed ID: 403412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [High performance liquid chromatographic assay of cephalexin in biological fluid].
    Takagishi Y; Iwamoto K; Nagata M; Kato H
    Yakugaku Zasshi; 1981 Sep; 101(9):843-7. PubMed ID: 7052235
    [No Abstract]   [Full Text] [Related]  

  • 36. Cephalexin concentration in the human ejaculate following oral and parenteral administration.
    Dalet F; Marina S; Gimeno E; Pomerol J
    Andrologia; 1978; 10(2):142-8. PubMed ID: 646144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absorption and excretion of cephalexin in health and acute illness.
    Dean S; Harding LK; Wise R; Wright N
    Eur J Clin Pharmacol; 1979 Aug; 16(1):73-4. PubMed ID: 499304
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effect of the combination of cephalexin with tobramycin on experimental pyelonephritis (author's transl)].
    Hatala M; Morávek J; Liska M; Modr Z; Prát V
    Cas Lek Cesk; 1976 May; 115(20-21):619-22. PubMed ID: 1277247
    [No Abstract]   [Full Text] [Related]  

  • 39. Serum levels and urinary excretion in humans of BL-S 578 (cefadroxil), a new semisynthetic cephalosporin.
    Prenna M; Ripa S
    Chemotherapy; 1980; 26(2):98-102. PubMed ID: 7363712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of cephalexin in calves after intravenous and subcutaneous administration.
    Garg SK; Chaudhary RK; Srivastava AK
    Acta Vet Hung; 1996; 44(2):195-201. PubMed ID: 8908743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.